Target intelligence / Profile preview

O6-alkylguanine lesion in DNA

Molecular classification
Other (DNA lesion/adduct)
01

Overview

Alkylation of guanine bases in DNA is a chemical modification, typically at the O6 position of guanine, resulting from exposure to endogenous or exogenous alkylating agents. This lesion can cause mutagenic mispairing (G:C to A:T mutations) during DNA replication and contributes to carcinogenesis and cytotoxicity. Cells possess direct DNA repair systems—primarily O6-methylguanine-DNA methyltransferase (MGMT)—that remove alkyl groups, thereby reversing the DNA damage. Many anticancer alkylating agents exert their cytotoxic effects by inducing guanine alkylation, while cancer resistance can emerge via increased MGMT activity which counteracts this lesion[1][2][4][5][7][9].

Other names
alkylated guanineO6-alkylguanine lesionO6-methylguanineguanine alkylationDNA alkylation adducts
02

Mechanism of action

Alkylating agents *cause* DNA alkylation at guanine, resulting in cytotoxic/mutagenic lesions[2][4][5][9]\nDNA repair agents *remove* alkyl groups, reversing alkylation[1][2][3][4][7]

03

Biological functions

MutagenesisGenetic instabilityCell death (if unrepaired)Activation of DNA repair pathwaysCarcinogenesis
04

Disease associations

Cancer (lesion formation leads to mutations and is involved in cancer development[2][4][5])Drug resistance in cancer (through repair mechanisms)Other (genomic instability, cytotoxicity)
05

Safety considerations

Mutagenicity and carcinogenicity (risk of off-target DNA damage)Development of chemoresistance via increased repair activity (e.g., elevated MGMT levels in tumors[2])Bone marrow suppression with alkylating drugs
06

Interacting drugs

Alkylating agents (Temozolomide, Nitrogen mustards, Melphalan, Cyclophosphamide, Busulfan, Dacarbazine, Streptozotocin, Procarbazine, BCNU)[4][5][9]

1 more in the full profile.

07

Biomarkers

Levels of alkylated guanine in DNA (O6-methylguanine)[2][4][5]

Beyond the preview

Go deeper on O6-alkylguanine lesion in DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O6-alkylguanine lesion in DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call